BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7524007)

  • 1. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.
    Dettelbach MA; Hirsch BE; Weissman JL
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):528-32. PubMed ID: 7524007
    [No Abstract]   [Full Text] [Related]  

  • 2. Virulence factors of Burkholderia cepacia.
    Nelson JW; Butler SL; Krieg D; Govan JR
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):89-97. PubMed ID: 7513590
    [No Abstract]   [Full Text] [Related]  

  • 3. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
    Butler SL; Doherty CJ; Hughes JE; Nelson JW; Govan JR
    J Clin Microbiol; 1995 Apr; 33(4):1001-4. PubMed ID: 7540623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia.
    Egan JJ; McNeil K; Bookless B; Gould K; Corris P; Higenbottam T; Webb AK; Woodcock AA
    Lancet; 1994 Aug; 344(8921):552-3. PubMed ID: 7520109
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying the killer in cystic fibrosis.
    Hearst JE; Elliott KE
    Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis and endobronchial pseudomonas infection.
    Høiby N
    Curr Opin Pediatr; 1993 Jun; 5(3):247-54. PubMed ID: 7690637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Superior vena cava obstruction without symptoms?].
    Freudenberger S; Kessler R; Canuet M; Boujan F; Santelmo N; Massard G; Falcoz PE
    Rev Mal Respir; 2011 Sep; 28(7):933-7. PubMed ID: 21943542
    [No Abstract]   [Full Text] [Related]  

  • 8. Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis.
    Balfour-Lynn IM; Ryley HC; Whitehead BF
    J R Soc Med; 1997; 90 Suppl 31(Suppl 31):59-64. PubMed ID: 9204013
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis and the pseudomonads.
    Wright KC
    Br J Biomed Sci; 1996 Jun; 53(2):140-5. PubMed ID: 8757691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas cepacia at summer camps for persons with cystic fibrosis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jun; 42(23):456-9. PubMed ID: 7684813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.
    Gómez MI; Prince A
    Curr Opin Pharmacol; 2007 Jun; 7(3):244-51. PubMed ID: 17418640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death after lung transplantation in cystic fibrosis patients infected with Burkholderia cepacia.
    Hopkins PM; Kidd TJ; Coulter C; Feather IH; Derrington P; Bell SC
    Am J Respir Crit Care Med; 2009 Feb; 179(3):257-8. PubMed ID: 19158331
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomonas cepacia--more than a harmless commensal?
    Lancet; 1992 Jun; 339(8806):1385-6. PubMed ID: 1375968
    [No Abstract]   [Full Text] [Related]  

  • 14. Nosocomially acquired Pseudomonas cepacia infection in patients with cystic fibrosis.
    Tablan OC
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):124-6. PubMed ID: 7683030
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia.
    Hodson ME
    Pediatr Pulmonol Suppl; 1995; 11():66-7. PubMed ID: 7547352
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas cepacia in cystic fibrosis.
    Stableforth DE; Smith DL
    Thorax; 1994 Jul; 49(7):629-30. PubMed ID: 7520606
    [No Abstract]   [Full Text] [Related]  

  • 17. Maintenance treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis.
    Høiby N; Koch C
    Thorax; 2000 May; 55(5):349-50. PubMed ID: 10770811
    [No Abstract]   [Full Text] [Related]  

  • 18. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
    Smyth AR
    Thorax; 2010 Apr; 65(4):281-2. PubMed ID: 20388748
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.